Literature DB >> 14719373

Signaling by the CD19/CD21 complex on B cells.

Robert H Carter1, Robert A Barrington.   

Abstract

Early studies, largely based on in vitro models, revealed potential functional roles for the components of the CD19/21/81 complex in B cell proliferation and antibody production. These studies also identified signal transduction pathways linked to these receptors. Over the last decade, studies on knockout mice defined the biologic functions of CD19, CD21 and CD81. This review focuses on current attempts to use these receptors as tools to understand how the immune system regulates responsiveness and tolerance, while correlating specific biochemical pathways with biologic function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14719373     DOI: 10.1159/000075685

Source DB:  PubMed          Journal:  Curr Dir Autoimmun        ISSN: 1422-2132


  12 in total

Review 1.  Germinal center structure and function: lessons from CD19.

Authors:  Robert H Carter; Riley Myers
Journal:  Semin Immunol       Date:  2008-02-19       Impact factor: 11.130

2.  Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity.

Authors:  Rei Watanabe; Nobuko Ishiura; Hiroko Nakashima; Yoshihiro Kuwano; Hitoshi Okochi; Kunihiko Tamaki; Shinichi Sato; Thomas F Tedder; Manabu Fujimoto
Journal:  J Immunol       Date:  2010-04-05       Impact factor: 5.422

Review 3.  Calcium signalling and cell-fate choice in B cells.

Authors:  Andrew M Scharenberg; Lisa A Humphries; David J Rawlings
Journal:  Nat Rev Immunol       Date:  2007-10       Impact factor: 53.106

4.  Generation and Validation of an Antibody to Canine CD19 for Diagnostic and Future Therapeutic Purposes.

Authors:  Kumudhini Preethi Haran; Alexandra Lockhart; Ailian Xiong; Enrico Radaelli; Patrick J Savickas; Avery Posey; Nicola J Mason
Journal:  Vet Pathol       Date:  2020-02-21       Impact factor: 2.221

5.  Comparison of mesenchymal stem cell markers in multiple human adult stem cells.

Authors:  Masoud Maleki; Farideh Ghanbarvand; Mohammad Reza Behvarz; Mehri Ejtemaei; Elham Ghadirkhomi
Journal:  Int J Stem Cells       Date:  2014-11       Impact factor: 2.500

6.  CD19: a biomarker for B cell development, lymphoma diagnosis and therapy.

Authors:  Kemeng Wang; Guoqing Wei; Delong Liu
Journal:  Exp Hematol Oncol       Date:  2012-11-29

7.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

Review 8.  EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B-Cell Lymphoma.

Authors:  Irene Papadouli; Jan Mueller-Berghaus; Claire Beuneu; Sahra Ali; Benjamin Hofner; Frank Petavy; Kyriaki Tzogani; Anne Miermont; Koenraad Norga; Olga Kholmanskikh; Tim Leest; Martina Schuessler-Lenz; Tomas Salmonson; Christian Gisselbrecht; Jordi Llinares Garcia; Francesco Pignatti
Journal:  Oncologist       Date:  2020-04-27       Impact factor: 5.837

9.  Peripheral CD19hi B cells exhibit activated phenotype and functionality in promoting IgG and IgM production in human autoimmune diseases.

Authors:  Zhicui Liu; Weihong Zeng; Xiangyang Huang; Shujun Wang; Jie Zheng; Meng Pan; Ying Wang
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

10.  Germline-activating mutations in PIK3CD compromise B cell development and function.

Authors:  Danielle T Avery; Alisa Kane; Tina Nguyen; Anthony Lau; Akira Nguyen; Helen Lenthall; Kathryn Payne; Wei Shi; Henry Brigden; Elise French; Julia Bier; Jana R Hermes; David Zahra; William A Sewell; Danyal Butt; Michael Elliott; Kaan Boztug; Isabelle Meyts; Sharon Choo; Peter Hsu; Melanie Wong; Lucinda J Berglund; Paul Gray; Michael O'Sullivan; Theresa Cole; Steven M Holland; Cindy S Ma; Christoph Burkhart; Lynn M Corcoran; Tri Giang Phan; Robert Brink; Gulbu Uzel; Elissa K Deenick; Stuart G Tangye
Journal:  J Exp Med       Date:  2018-07-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.